David Arkowitz | CFO |
Dan Deardorf | SVP of Commercial |
Michael Clayman | Co-Founder, President, CEO |
Scott Young | VP of Corporate Communications & IR |
Dan Busby | RBC Capital Markets |
Elliot Wilbur | Raymond James |
Serge Belanger | Needham and Company |
Carl Byrnes | Northland Securities |
Bruce Jackson | Lake Street Capital |
Patrick Trucchio | Berenberg Capital Markets |
Ken Trbovich | Janney |
Good afternoon, ladies and gentlemen, and welcome to the Flexion Therapeutics Q1 2018 Financial Results Conference Call. My name is Kevin and I will be your coordinator today. [Operator Instructions] I will now turn the call over to the company.
Thank you, Kevin. Good afternoon.